233 related articles for article (PubMed ID: 34569252)
1. Circulating extracellular vesicles of patients with steroid-sensitive nephrotic syndrome have higher RAC1 and induce recapitulation of nephrotic syndrome phenotype in podocytes.
Eroglu FK; Yazar V; Guler U; Yıldırım M; Yildirim T; Gungor T; Celikkaya E; Karakaya D; Turay N; Ciftci Dede E; Korkusuz P; Salih B; Bulbul M; Gursel I
Am J Physiol Renal Physiol; 2021 Nov; 321(5):F659-F673. PubMed ID: 34569252
[TBL] [Abstract][Full Text] [Related]
2. Active proteases in nephrotic plasma lead to a podocin-dependent phosphorylation of VASP in podocytes via protease activated receptor-1.
Harris JJ; McCarthy HJ; Ni L; Wherlock M; Kang H; Wetzels JF; Welsh GI; Saleem MA
J Pathol; 2013 Apr; 229(5):660-71. PubMed ID: 23436459
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the protein kinase MK-2 protects podocytes from nephrotic syndrome-related injury.
Pengal R; Guess AJ; Agrawal S; Manley J; Ransom RF; Mourey RJ; Benndorf R; Smoyer WE
Am J Physiol Renal Physiol; 2011 Sep; 301(3):F509-19. PubMed ID: 21613416
[TBL] [Abstract][Full Text] [Related]
4. Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome.
Koshikawa M; Mukoyama M; Mori K; Suganami T; Sawai K; Yoshioka T; Nagae T; Yokoi H; Kawachi H; Shimizu F; Sugawara A; Nakao K
J Am Soc Nephrol; 2005 Sep; 16(9):2690-701. PubMed ID: 15987752
[TBL] [Abstract][Full Text] [Related]
5. ARHGDIA mutations cause nephrotic syndrome via defective RHO GTPase signaling.
Gee HY; Saisawat P; Ashraf S; Hurd TW; Vega-Warner V; Fang H; Beck BB; Gribouval O; Zhou W; Diaz KA; Natarajan S; Wiggins RC; Lovric S; Chernin G; Schoeb DS; Ovunc B; Frishberg Y; Soliman NA; Fathy HM; Goebel H; Hoefele J; Weber LT; Innis JW; Faul C; Han Z; Washburn J; Antignac C; Levy S; Otto EA; Hildebrandt F
J Clin Invest; 2013 Aug; 123(8):3243-53. PubMed ID: 23867502
[TBL] [Abstract][Full Text] [Related]
6. Urine-derived podocytes from steroid resistant nephrotic syndrome patients as a model for renal-progenitor derived extracellular vesicles effect and drug screening.
Tanzi A; Buono L; Grange C; Iampietro C; Brossa A; Arcolino FO; Arigoni M; Calogero R; Perin L; Deaglio S; Levtchenko E; Peruzzi L; Bussolati B
Res Sq; 2024 Feb; ():. PubMed ID: 38464119
[TBL] [Abstract][Full Text] [Related]
7. Human Th17 cells produce a soluble mediator that increases podocyte motility via signaling pathways that mimic PAR-1 activation.
May CJ; Welsh GI; Chesor M; Lait PJ; Schewitz-Bowers LP; Lee RWJ; Saleem MA
Am J Physiol Renal Physiol; 2019 Oct; 317(4):F913-F921. PubMed ID: 31339775
[TBL] [Abstract][Full Text] [Related]
8. Rac1 activation in podocytes induces the spectrum of nephrotic syndrome.
Robins R; Baldwin C; Aoudjit L; Côté JF; Gupta IR; Takano T
Kidney Int; 2017 Aug; 92(2):349-364. PubMed ID: 28483380
[TBL] [Abstract][Full Text] [Related]
9. Disease-causing mutations of RhoGDIα induce Rac1 hyperactivation in podocytes.
Auguste D; Maier M; Baldwin C; Aoudjit L; Robins R; Gupta IR; Takano T
Small GTPases; 2016 Apr; 7(2):107-21. PubMed ID: 26726844
[TBL] [Abstract][Full Text] [Related]
10. Podocyte protease activated receptor 1 stimulation in mice produces focal segmental glomerulosclerosis mirroring human disease signaling events.
May CJ; Chesor M; Hunter SE; Hayes B; Barr R; Roberts T; Barrington FA; Farmer L; Ni L; Jackson M; Snethen H; Tavakolidakhrabadi N; Goldstone M; Gilbert R; Beesley M; Lennon R; Foster R; Coward R; Welsh GI; Saleem MA
Kidney Int; 2023 Aug; 104(2):265-278. PubMed ID: 36940798
[TBL] [Abstract][Full Text] [Related]
11. Salvianolic acid A attenuates steroid resistant nephrotic syndrome through suPAR/uPAR-αvβ3 signaling Inhibition.
Li X; Qi D; Wang MY; Ji K; Xie QL; Wang Y; Du SH; Fan HY
J Ethnopharmacol; 2021 Oct; 279():114351. PubMed ID: 34157324
[TBL] [Abstract][Full Text] [Related]
12. Heparanase activity is dysregulated in children with steroid-sensitive nephrotic syndrome.
Holt RC; Webb NJ; Ralph S; Davies J; Short CD; Brenchley PE
Kidney Int; 2005 Jan; 67(1):122-9. PubMed ID: 15610235
[TBL] [Abstract][Full Text] [Related]
13. Plasma levels of oxidative stress in children with steroid-sensitive nephrotic syndrome and their predictive value for relapse frequency.
Fan A; Jiang X; Mo Y; Tan H; Jiang M; Li J
Pediatr Nephrol; 2016 Jan; 31(1):83-8. PubMed ID: 26341250
[TBL] [Abstract][Full Text] [Related]
14. Loss of Rho-GDIα sensitizes podocytes to lipopolysaccharide-mediated injury.
Robins R; Baldwin C; Aoudjit L; Gupta IR; Takano T
Am J Physiol Renal Physiol; 2015 Jun; 308(11):F1207-16. PubMed ID: 25503727
[TBL] [Abstract][Full Text] [Related]
15. Extracellular vesicles from focal segmental glomerulosclerosis pediatric patients induce STAT3 activation and mesangial cell proliferation.
Pekkucuksen NT; Liu LP; Aly R; Shoemaker LR; Alli AA
PLoS One; 2022; 17(11):e0274598. PubMed ID: 36374911
[TBL] [Abstract][Full Text] [Related]
16. Podocyte and endothelial cell injury lead to nephrotic syndrome in proliferative lupus nephritis.
Nawata A; Hisano S; Shimajiri S; Wang KY; Tanaka Y; Nakayama T
Histopathology; 2018 Jun; 72(7):1084-1092. PubMed ID: 29247494
[TBL] [Abstract][Full Text] [Related]
17. Atypical IgM on T cells predict relapse and steroid dependence in idiopathic nephrotic syndrome.
Colucci M; Carsetti R; Rosado MM; Cascioli S; Bruschi M; Candiano G; Corpetti G; Giardino L; Serafinelli J; Giannone C; Ghiggeri GM; Rastaldi MP; Sitia R; Emma F; Vivarelli M
Kidney Int; 2019 Oct; 96(4):971-982. PubMed ID: 31285081
[TBL] [Abstract][Full Text] [Related]
18. The Role of Trio, a Rho Guanine Nucleotide Exchange Factor, in Glomerular Podocytes.
Maier M; Baldwin C; Aoudjit L; Takano T
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29415466
[TBL] [Abstract][Full Text] [Related]
19. microRNA in Extracellular Vesicles Released by Damaged Podocytes Promote Apoptosis of Renal Tubular Epithelial Cells.
Jeon JS; Kim E; Bae YU; Yang WM; Lee H; Kim H; Noh H; Han DC; Ryu S; Kwon SH
Cells; 2020 Jun; 9(6):. PubMed ID: 32517075
[TBL] [Abstract][Full Text] [Related]
20. KANK deficiency leads to podocyte dysfunction and nephrotic syndrome.
Gee HY; Zhang F; Ashraf S; Kohl S; Sadowski CE; Vega-Warner V; Zhou W; Lovric S; Fang H; Nettleton M; Zhu JY; Hoefele J; Weber LT; Podracka L; Boor A; Fehrenbach H; Innis JW; Washburn J; Levy S; Lifton RP; Otto EA; Han Z; Hildebrandt F
J Clin Invest; 2015 Jun; 125(6):2375-84. PubMed ID: 25961457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
